STAT3 and myelodysplastic syndrome: Other adverse effects of IFN-γ include the activation of the proleukemogenic STAT3 pathway and the ability to accelerate the apoptosis of normal hematopoietic cells in a low-risk MDS (Lr-MDS) [77,103,104].